Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Using certain small proteins with a growth factor and specific materials can increase the creation of neurons from stem cells.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

To stop online sexism, both men and women need to change how they act.

Spironolactone did not make hair thinner in women with excess hair growth.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Acne is an important sign of androgen excess disorders in women.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

A new gel containing minoxidil can treat hair loss effectively, potentially reducing side effects and improving treatment.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.